02:30 PM
The Decision: Why Go Public and Why Now?
by Danny Wettreich, GreenBank Capital , James Silvester, Fusion Road , Lance Kimmel, SEC Law Firm , Eric Stein, Szaferman Lakind , John Hogoboom, Lowenstein Sandler ,
Why now? If not now, when? Why go public at all? New options for private company capital formation and liquidity. Considering an alternative public offering.03:15 PM
The Preparation: Building Your Story and Your Team
by Joseph Lucosky, Lucosky Brookman , Jay Norris, Malone Bailey , Adam Epstein, Third Creek Advisors , David Weild, IssuWorks ,
Earnings growth is the only thing. Addressing your capital structure. Technology and IP. Internal controls. The audit. Choosing independent directors. Assessing your legal and accounting representation. Hiring a banker instead of a brand.04:00 PM
04:15 PM
The Execution: Is Timing Everything?
by Rob Schechter, C.I. Eckstein & Company , Michael Tomasulo, AHT Insurance , Jonathan Gellis, Worldwide Stock Transfer , Joseph Balagot, Dawson James ,
Testing the waters with a confidential filing. Setting goals for the roadshow. The new rules on investor communications. The difference between IR and stock promotion. EDGAR filing, stock transfer and the DTC. Engineering the Pop.05:00 PM
The Aftermarket: Thriving in the Public Realm
by David Cohen, National Securities , Sheldon Kraft, SNN, Inc. , Steven Skolnick, Lowenstein Sandler , Ted Haberfield, MZ Group ,
The two jobs of a public CEO: managing the company and managing the stock. Establishing your investor and media profiles. Market messaging of corporate announcements. Managing the Fade. Follow on financings. When a problem is a crisis.05:45 PM
Q&A Wrap Up
Open Q&A with the full workshop faculty.06:00 PM
Growth Capital Expo Welcome Reception
by Julius Anderegg, Consul General of Switzerland , Dr. Frank Grossman, Chief Executive Officer, Orphanbiotec Foundation ,
Sponsored by the Swiss national government in support of the work of Dr. Frank Grossman, of the Orphanbiotec Foundation of Zurich. The Swiss Consul General, Mssr. Julius Anderegg, will introduce Dr. Grossman, who will offer a brief explanation of Orphanbiotec's mission and work to develop and distribute treatments for rare diseases. Cocktails and hor d'vouerves will be served.09:25 AM
10:15 AM
10:45 AM
Non-PIPE Financing Options for Public Emerging Growth Companies: Structured Equity-linked Debt, Tranched Offerings, Registered Directs, CMPOs & At-the-Market Offerings
by Richard Gormley, Lazard , Justin Keener, JMJ Financial , Todd Wyche, Brinson Patrick Securities , Jim Alfaro, Maxim Group , Joshua Feldman, Cantor Fitzgerald , Steven Maletzky, William Blair ,
11:40 AM
12:30 PM
1:55 PM
02:45 PM
03:15 PM
Alternative Methods and Structures for Bringing Companies Public: Funded Reverse Mergers, Mini-SPACs, and Direct Public Offerings
by Barry Grossman, Ellenoff Grossman & Schole , Kristen Baracy, Synergy Law Group , Jolie Kahn, Fellheimer & Eichen , Bill Hicks, Mintz Levin , David Feldman, Richardson Patel ,
04:10 PM
04:40 PM
08:00 AM
09:00 AM
09:30 AM
10:20 AM
10:50 AM
11:45 AM
12:30 PM
01:20 PM
02:10 PM
By Popular Demand: Opportunities for Institutional Investment in Marijuana-related Companies
by Dr. Mark Rabe, Medical Marijuana Sciences , Dr. Lawrence May, Tauriga Sciences , Khurshid Khoja, Greenbridge Corporate Counsel , Justin Hartfield, Ghost Group , Troy Dayton, The ArcView Group , Douglas Leighton, Dutchess Capital ,
